An Open Label, Long Term Safety Study of REN001 in Primary Mitochondrial Myopathy Patients (Stride Ahead)
Clinical trial NCT05267574 · TERMINATED
Trial details
- NCT number
- NCT05267574
- Sponsor
- Reneo Pharma Ltd
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-01
- Primary completion
- 2023-12-14
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.